Interestingly, ZMYND8-induced changes in metabolic intermediate lactate in breast cancer cells, as well as in mouse serum, significantly impact the immune cell invasion and CD8+ T cell activity in the tumor microenvironment. Here, ZMYND8 is linked to neoplasm.